Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-24

FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Zenatane (isotretinoin) by BluePoint Laboratories (ANDA 202099).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENATANE (Isotretinoin)

Snippet

SUPPL AP for ZENATANE (ISOTRETINOIN)